Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Richman

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|May 28, 1979
Monoclonal antibodies against purified nicotinic acetylcholine receptorC M Gomez, D P Richman, P W Berman, et al.
Annals of the New York Academy of Sciences|July 21, 1998
A role for alpha(187-199) in the conversion of agonist binding energy to the opening of the acetylcholine receptor ion channelR H Fairclough, E Gudipati, M Y Lin, et al.
Nature|February 9, 1984
Myelin-associated glycoprotein in human retinaK Stefansson, M L Molnar, L S Marton, et al.
Journal of Molecular Biology|September 15, 1998
Mapping the mAb 383C epitope to alpha 2(187-199) of the Torpedo acetylcholine receptor on the three-dimensional modelR H Fairclough, G M Twaddle, E Gudipati, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Effector mechanisms of myasthenic antibodiesD P Richman, R L Wollmann, R A Maselli, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Antibody effector mechanisms in myasthenia gravis. The complement hypothesisD P Richman, M A Agius, C A Kirvan, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 8, 2001
Thymectomy in the treatment of ocular myasthenia gravisP F Roberts, F Venuta, E Rendina, et al.
Muscle & Nerve|November 1, 1993
Neuromuscular transmission in amyotrophic lateral sclerosisR A Maselli, R L Wollman, C Leung, et al.
Muscle & Nerve|October 27, 1997
Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic studyR A Maselli, W Ellis, R N Mandler, et al.
Neurology|July 27, 2001
Presynaptic congenital myasthenic syndrome due to quantal release deficiencyR A Maselli, D Z Kong, C M Bowe, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|May 28, 1979
Monoclonal antibodies against purified nicotinic acetylcholine receptorC M Gomez, D P Richman, P W Berman, et al.
Annals of the New York Academy of Sciences|July 21, 1998
A role for alpha(187-199) in the conversion of agonist binding energy to the opening of the acetylcholine receptor ion channelR H Fairclough, E Gudipati, M Y Lin, et al.
Nature|February 9, 1984
Myelin-associated glycoprotein in human retinaK Stefansson, M L Molnar, L S Marton, et al.
Journal of Molecular Biology|September 15, 1998
Mapping the mAb 383C epitope to alpha 2(187-199) of the Torpedo acetylcholine receptor on the three-dimensional modelR H Fairclough, G M Twaddle, E Gudipati, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Effector mechanisms of myasthenic antibodiesD P Richman, R L Wollmann, R A Maselli, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Antibody effector mechanisms in myasthenia gravis. The complement hypothesisD P Richman, M A Agius, C A Kirvan, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 8, 2001
Thymectomy in the treatment of ocular myasthenia gravisP F Roberts, F Venuta, E Rendina, et al.
Muscle & Nerve|November 1, 1993
Neuromuscular transmission in amyotrophic lateral sclerosisR A Maselli, R L Wollman, C Leung, et al.
Muscle & Nerve|October 27, 1997
Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic studyR A Maselli, W Ellis, R N Mandler, et al.
Neurology|July 27, 2001
Presynaptic congenital myasthenic syndrome due to quantal release deficiencyR A Maselli, D Z Kong, C M Bowe, et al.
Pageof 8